• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野生型心脏淀粉样变性患者的生存分层预测因素。

Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

机构信息

Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

Department of Psychology, University of Heidelberg, Heidelberg, Germany.

出版信息

Clin Res Cardiol. 2018 Feb;107(2):158-169. doi: 10.1007/s00392-017-1167-1. Epub 2017 Sep 27.

DOI:10.1007/s00392-017-1167-1
PMID:28956153
Abstract

OBJECTIVES

To analyze clinical predictors of mortality in wild-type transthyretin amyloidosis (wt-ATTR).

METHODS

In total, 191 patients (73.8 ± 0.5 years; 176 males, 15 females) with histologically proven wt-ATTR amyloidosis and genetic exclusion of a transthyretin gene variant were included. Comprehensive clinical characteristics, ECG, biomarkers, and echocardiography were analyzed retrospectively. Strain analyses were performed offline using TomTec Imaging Systems, Germany. Univariable and multivariable analyses predicting all-cause mortality were carried out.

RESULTS

Patients presented with significant heart failure (NYHA 2.5 ± 0.8; NT-proBNP 3644 (4981) pg/ml; LV ejection fraction 45.8 ± 15.0%). LogNT-proBNP correlated with indicators of disease severity. Similar results were obtained for basal and midventricular, but not apical longitudinal strain. During median follow-up of 26.2 ± 1.7 months 46 (25.5%) patients died (40 males, 23%; six females, 40%). In female patients 1-/2-year survival was lower [92.9/67.7%; median survival 30.6 (21.1-40.1) months] when compared to male patients [96.5%/86.6%; median survival 63.9 (45.8-82.0) months]. Parameters associated with survival were NT-proBNP, NYHA class, heart rate, midventricular longitudinal strain, mitral annular plane systolic excursion (MAPSE), Karnofsky Index, systolic blood pressure, estimated glomerular filtration rate. Multivariable analysis revealed MAPSE and NT-proBNP as independent predictors of mortality in the whole cohort and midventricular strain in the subgroup of patients in sinus rhythm.

CONCLUSIONS

No sex-specific bias was observed between male and female patients with wt-ATTR regarding age at onset and morphological characteristics. Multivariable analysis revealed MAPSE and NT-proBNP as independent predictors of survival in the whole cohort, whereas midventricular longitudinal strain was the only independent predictor in patients in sinus rhythm.

摘要

目的

分析野生型转甲状腺素蛋白淀粉样变(wt-ATTR)患者的死亡临床预测因子。

方法

共纳入 191 例组织学证实的 wt-ATTR 淀粉样变且排除转甲状腺素基因变异的患者。回顾性分析了全面的临床特征、心电图、生物标志物和超声心动图。使用德国 TomTec 成像系统离线进行应变分析。进行单变量和多变量分析以预测全因死亡率。

结果

患者表现出明显的心衰(NYHA 2.5±0.8;NT-proBNP 3644(4981)pg/ml;左心室射血分数 45.8±15.0%)。LogNT-proBNP 与疾病严重程度的指标相关。基底和中层心室的应变结果相似,但心尖纵向应变结果不同。在 26.2±1.7 个月的中位随访期间,46 例(25.5%)患者死亡(40 例男性,23%;6 例女性,40%)。与男性患者相比,女性患者的 1 年和 2 年生存率较低[92.9%/67.7%;中位生存时间 30.6(21.1-40.1)个月]。与生存相关的参数包括 NT-proBNP、NYHA 分级、心率、中层心室纵向应变、二尖瓣环平面收缩期位移(MAPSE)、卡诺夫斯基指数、收缩压、估算肾小球滤过率。多变量分析显示,MAPSE 和 NT-proBNP 是整个队列死亡率的独立预测因子,而在窦性心律患者亚组中,中层心室应变是唯一的独立预测因子。

结论

在 wt-ATTR 患者中,男性和女性在发病年龄和形态特征方面没有性别特异性差异。多变量分析显示,MAPSE 和 NT-proBNP 是整个队列生存率的独立预测因子,而在窦性心律患者中,中层心室纵向应变是唯一的独立预测因子。

相似文献

1
Predictors of survival stratification in patients with wild-type cardiac amyloidosis.野生型心脏淀粉样变性患者的生存分层预测因素。
Clin Res Cardiol. 2018 Feb;107(2):158-169. doi: 10.1007/s00392-017-1167-1. Epub 2017 Sep 27.
2
Noninvasive risk stratification of patients with transthyretin amyloidosis.转甲状腺素蛋白淀粉样变性患者的无创风险分层。
JACC Cardiovasc Imaging. 2014 May;7(5):502-10. doi: 10.1016/j.jcmg.2014.03.002. Epub 2014 Apr 9.
3
Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.二维斑点追踪超声心动图对左心室射血分数保留型轻链型淀粉样变性患者预后的评估:对现行预后分期系统的补充价值。
JACC Cardiovasc Imaging. 2017 Apr;10(4):398-407. doi: 10.1016/j.jcmg.2016.04.008. Epub 2016 Sep 14.
4
Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.心脏磁共振和超声心动图检查发现的淀粉样变性所致的心脏结构和功能改变及其预后价值。
JACC Cardiovasc Imaging. 2019 May;12(5):823-833. doi: 10.1016/j.jcmg.2018.02.016. Epub 2018 Apr 18.
5
Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.转甲状腺素蛋白和 AL 型心脏淀粉样变性预后标志物的鉴定。
Amyloid. 2016 Sep;23(3):194-202. doi: 10.1080/13506129.2016.1221815. Epub 2016 Sep 20.
6
Prognostic implication of relative regional strain ratio in cardiac amyloidosis.心脏淀粉样变中相对区域应变率的预后意义
Heart. 2016 May 15;102(10):748-54. doi: 10.1136/heartjnl-2015-308657. Epub 2016 Feb 1.
7
Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).转甲状腺素蛋白淀粉样变性患者的基因型和表型对心脏生物标志物的影响——转甲状腺素蛋白淀粉样变性结局调查(THAOS)报告
PLoS One. 2017 Apr 6;12(4):e0173086. doi: 10.1371/journal.pone.0173086. eCollection 2017.
8
Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.心脏淀粉样变性的亚型特异性相互作用与预后
J Am Heart Assoc. 2016 Mar 24;5(3):e002877. doi: 10.1161/JAHA.115.002877.
9
Changes of clinical characteristics, distribution of red flags and prognosis in contemporary patients with wild-type transthyretin amyloidosis cardiomyopathy.当代野生型转甲状腺素蛋白淀粉样变性心肌病患者的临床特征变化、红色信号分布和预后。
Ann Med. 2024 Dec;56(1):2398735. doi: 10.1080/07853890.2024.2398735. Epub 2024 Sep 9.
10
Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.转甲状腺素蛋白心脏淀粉样变中焦磷酸盐摄取的区域差异及其对死亡率的影响。
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):234-242. doi: 10.1016/j.jcmg.2017.06.020. Epub 2017 Oct 5.

引用本文的文献

1
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis.轻链和转甲状腺素蛋白淀粉样变性的超声心动图风险分层:一项荟萃分析。
Eur Heart J Open. 2025 Aug 22;5(4):oeaf078. doi: 10.1093/ehjopen/oeaf078. eCollection 2025 Jul.
2
Vutrisiran in Transthyretin Amyloidosis: A Pooled Safety Analysis of HELIOS-A and HELIOS-B.伏硫西汀治疗转甲状腺素蛋白淀粉样变性:HELIOS - A和HELIOS - B的汇总安全性分析
JACC Adv. 2025 Aug 22;4(9):102066. doi: 10.1016/j.jacadv.2025.102066.
3
Liver stiffness as a prognostic parameter and tool for risk stratification in advanced cardiac transthyretin amyloidosis.

本文引用的文献

1
Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.基于多模态成像的心脏转甲状腺素蛋白淀粉样变性的诊断
Clin Res Cardiol. 2017 Jun;106(6):471-473. doi: 10.1007/s00392-017-1092-3. Epub 2017 Mar 16.
2
Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis.系统性轻链淀粉样变性中左侧瓣膜增厚的患病率及预后影响
Clin Res Cardiol. 2017 May;106(5):331-340. doi: 10.1007/s00392-016-1058-x. Epub 2016 Dec 8.
3
Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study.
肝脏硬度作为晚期心脏转甲状腺素蛋白淀粉样变性的预后参数和风险分层工具。
Clin Res Cardiol. 2024 Aug 20. doi: 10.1007/s00392-024-02513-3.
4
Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review.六分钟步行试验作为心肌病临床试验的临床终点,包括ATTR-CM:系统文献回顾。
J Comp Eff Res. 2024 Jul;13(7):e230158. doi: 10.57264/cer-2023-0158. Epub 2024 Jun 13.
5
Diagnostic significance of paradoxical left ventricular hypertrophy in detecting cardiac amyloidosis.矛盾性左心室肥厚在检测心脏淀粉样变性中的诊断意义。
Int J Cardiol Heart Vasc. 2023 Oct 13;49:101279. doi: 10.1016/j.ijcha.2023.101279. eCollection 2023 Dec.
6
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction.基于机器学习的三维自动左心腔指标定量评估心肌收缩分数:在肥厚型表型和正常射血分数中的诊断效用
J Clin Med. 2023 Aug 25;12(17):5525. doi: 10.3390/jcm12175525.
7
Sex differences in transthyretin cardiac amyloidosis.转甲状腺素蛋白心脏淀粉样变性的性别差异。
Heart Fail Rev. 2024 Mar;29(2):321-330. doi: 10.1007/s10741-023-10339-w. Epub 2023 Aug 11.
8
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review.转甲状腺素蛋白淀粉样变心肌病中的每搏输出量和心肌收缩分数:一项系统评价。
Front Cardiovasc Med. 2023 Jan 27;10:1085824. doi: 10.3389/fcvm.2023.1085824. eCollection 2023.
9
Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosis.转甲状腺素蛋白淀粉样变性心肌病患者的性别差异——从诊断到预后。
Eur J Heart Fail. 2022 Dec;24(12):2355-2363. doi: 10.1002/ejhf.2646. Epub 2022 Aug 16.
10
A systematic review and meta-analysis of the prevalence of transthyretin amyloidosis in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者中甲状腺转运蛋白淀粉样变患病率的系统评价和荟萃分析。
Am J Cardiovasc Dis. 2022 Jun 15;12(3):102-111. eCollection 2022.
急性心力衰竭住院男性和女性早期呼吸困难缓解的性别差异:来自RELAX-AHF研究的见解。
Clin Res Cardiol. 2017 Apr;106(4):280-292. doi: 10.1007/s00392-016-1051-4. Epub 2016 Nov 12.
4
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.非活检诊断心脏转甲状腺素淀粉样变性。
Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.
5
Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging: comparison of high-resolution speckle tracking and feature tracking.二维超声心动图和心脏磁共振成像评估左心室力学:高分辨率斑点追踪和特征追踪的比较。
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1370-1378. doi: 10.1093/ehjci/jew042. Epub 2016 Mar 24.
6
Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.腕管综合征:系统性野生型转甲状腺素蛋白淀粉样变性(ATTRwt)的常见初始症状。
Amyloid. 2016;23(1):58-63. doi: 10.3109/13506129.2015.1135792. Epub 2016 Feb 8.
7
Prognostic implication of relative regional strain ratio in cardiac amyloidosis.心脏淀粉样变中相对区域应变率的预后意义
Heart. 2016 May 15;102(10):748-54. doi: 10.1136/heartjnl-2015-308657. Epub 2016 Feb 1.
8
Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.二维应变超声心动图评估心脏淀粉样变的纵向左心室功能障碍的原因和后果。
JACC Cardiovasc Imaging. 2016 Feb;9(2):126-38. doi: 10.1016/j.jcmg.2015.05.014. Epub 2016 Jan 6.
9
Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study.绿茶提取物治疗野生型转甲状腺素蛋白淀粉样变性患者:一项观察性研究。
Drug Des Devel Ther. 2015 Dec 4;9:6319-25. doi: 10.2147/DDDT.S96893. eCollection 2015.
10
The transthyretin amyloidoses: advances in therapy.转甲状腺素蛋白淀粉样变性:治疗进展
Postgrad Med J. 2015 Aug;91(1078):439-48. doi: 10.1136/postgradmedj-2014-133224. Epub 2015 Jun 5.